- 期刊
- OpenAccess
以3-0 Ticron使用額肌懸吊法治療先天性眼瞼下垂的初步報告
Frontalis Suspension with 3-0 Ticron Suture
摘要
本文為五例使用3-0 Ticron矯正眼瞼下垂的初步報告。Ticron是一種不可吸收的手術縫線。它的張力強度特高，無彈性疲乏現象，同時和組織的相容性佳。一般Ticron常被用於心臟血管外科中大血管的縫合及瓣膜的置換手術。 本系列病例追蹤的時間從六個月到十八個月，平均九點五個月。術後評估依眼瞼的位置分為良好，尚可及不良。良好者五例中佔四例(80.0%)；不良者一例(20.0%)；尚可者無。五例中有一例復發眼瞼下垂現象。除此之外皆沒有感染，排斥，暴露性角膜炎或肉芽組織形成。根據我們的初步觀察，在進行額肌懸吊術的諸多材料之中，3-0 Ticron似乎不失為、一個穩定的材料。
關鍵字
無資料並列摘要
Ticron is the commercial name of a nonabsorbable surgical suture, used in valve replacement surgeries, large vessels repair, and sternum sutures. It has the advantages of pliability and durable tensile strength. We used this material as the suspensory material in the operations of congenital ptosis. A total of five lids from five patients were included in the study between 1994 and 1996. The follow-up period ranged from six to 18 months, with an average of nine and a half months. Post-operated lid levels were judge as good, fair, or poor. Good results occurred in four patients (80.0%), fair in zero (0%), and poor in one (20.0%). No infection, exposure keratitis, or suture granuloma was found in any of the five cases, be it good or poor. The Ticron might provide a stable and durable repair of ptosis with poor or absent levator muscle function, but based on this preliminary trial, a longer follow-up will be necessary to clarify its role in the future.